Pharmacodynamics Overview (osmosis)
47 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What role do receptors play in pharmacodynamics?

  • They transport medications throughout the body.
  • They prevent any interaction with medications.
  • They alter their shape or activity when a ligand binds. (correct)
  • They directly dismantle medications upon entry.

    • How does a full agonist differ from a partial agonist in terms of receptor activation?

  • A full agonist cannot bind to receptors at all.
  • A full agonist binds but fails to activate the receptor.
  • A full agonist has no effect on receptor activation.
  • A full agonist produces a maximal response, while a partial agonist does not. (correct)

    • What happens to the potency of a full agonist when a partial antagonist is present?

  • It decreases. (correct)
  • It remains the same.
  • It becomes irrelevant.
  • It increases due to competition.

    • What impact does increasing the dose of a full agonist have when a partial agonist is present?

    <p>It displaces the partial agonist from the receptor and maintains maximal response.</p> Signup and view all the answers

    What is Emax in pharmacodynamics?

    <p>It represents the highest response achieved by an agonist.</p> Signup and view all the answers

    Which statement correctly describes competitive antagonists?

    <p>They can be overcome by increasing agonist concentration.</p> Signup and view all the answers

    Which characteristic distinguishes non-competitive antagonists from competitive antagonists?

    <p>They do not change the ED50.</p> Signup and view all the answers

    What does the effective dose ED50 represent in the context of dose-response relationships?

    <p>The dose required to produce 50% of the maximal effect.</p> Signup and view all the answers

    What is the effect of a non-competitive antagonist on the maximal effect (Emax) of an agonist?

    <p>It decreases the Emax.</p> Signup and view all the answers

    In a pharmacodynamics context, what is the primary difference between agonists and antagonists?

    <p>Agonists activate receptors, antagonists inhibit activation by other ligands.</p> Signup and view all the answers

    Why is the dose-response curve plotted on a logarithmic scale for the dose given?

    <p>To accommodate a wide range of doses and responses.</p> Signup and view all the answers

    Which scenario describes an effect of a competitive antagonist?

    <p>It shifts the dose-response curve to the right.</p> Signup and view all the answers

    What happens when both a full agonist and a partial agonist occupy the same receptors?

    <p>The full agonist will compete and can displace the partial agonist, achieving Emax.</p> Signup and view all the answers

    What is a key characteristic of partial agonists?

    <p>They can only produce a submaximal response.</p> Signup and view all the answers

    In what way does competitive antagonism impact agonist potency and efficacy?

    <p>Decreases potency, does not affect efficacy.</p> Signup and view all the answers

    What is meant by the term 'surmountability' in pharmacology?

    <p>The potential to overcome inhibition by increasing agonist concentration.</p> Signup and view all the answers

    What is a consequence of continuous amphetamine use on nerve terminals?

    <p>Depletion of amine stores</p> Signup and view all the answers

    What mechanism underlies alcohol tolerance in the body?

    <p>Increased activity of liver enzymes</p> Signup and view all the answers

    What physiological adaptation might occur with chronic use of diuretics like thiazides?

    <p>Heightened activity of the renin-angiotensin-aldosterone system</p> Signup and view all the answers

    How does the body adapt to the effects of nitroglycerin over time?

    <p>Increased tolerance to the vasodilation effect</p> Signup and view all the answers

    What might result from rapid consecutive use of amphetamines?

    <p>Decreased neurotransmitter release</p> Signup and view all the answers

    What is the term used to describe the rapid decrease in a receptor's response to an agonist after initial exposure?

    <p>Desensitization</p> Signup and view all the answers

    Which mechanism is primarily responsible for tolerance over time rather than immediate response?

    <p>Decreased receptor synthesis</p> Signup and view all the answers

    What process involves the receptor being engulfed and sent to the lysosome for digestion?

    <p>Endocytosis</p> Signup and view all the answers

    Which type of receptor modification occurs when the receptors are unable to activate their signaling pathways?

    <p>Uncoupling</p> Signup and view all the answers

    Which substance is mentioned as causing the release of amines from nerve terminals leading to receptor desensitization?

    <p>Amphetamine</p> Signup and view all the answers

    What type of receptors are specifically phosphorylated by G protein coupled receptor kinases?

    <p>G-protein coupled receptors</p> Signup and view all the answers

    What phenomenon leads to a higher dose requirement for drug effectiveness in chronic users?

    <p>Tolerance</p> Signup and view all the answers

    What happens to the number of receptors as a result of chronic exposure to agonists?

    <p>Decreased receptor synthesis</p> Signup and view all the answers

    Where are intracellular receptors typically located within a cell?

    <p>In the cytoplasm or nucleus</p> Signup and view all the answers

    What type of receptors form channels that open upon binding a specific ligand?

    <p>Ligand-gated ion channels</p> Signup and view all the answers

    How do enzyme-coupled receptors typically function?

    <p>They often have kinase activity at their intracellular end.</p> Signup and view all the answers

    What initiates the activity of G-protein coupled receptors?

    <p>The release of GDP from the alpha subunit</p> Signup and view all the answers

    Which of the following statements is true regarding cell-surface receptors?

    <p>They include ligand-gated, enzyme-coupled, and G-protein coupled receptors.</p> Signup and view all the answers

    What type of receptor has a structure that spans the membrane seven times?

    <p>G-protein coupled receptors</p> Signup and view all the answers

    What happens when a ligand binds to an enzyme-coupled receptor?

    <p>There is a conformational change activating a kinase.</p> Signup and view all the answers

    What do G-protein coupled receptors activate upon ligand binding?

    <p>Guanine nucleotide-binding proteins</p> Signup and view all the answers

    What is the primary role of the enzyme adenylate cyclase in the signaling pathway?

    <p>To stimulate the production of cyclic AMP</p> Signup and view all the answers

    How does the EC50 value relate to the potency of a medication?

    <p>It is directly proportional; lower EC50 indicates higher potency.</p> Signup and view all the answers

    What happens to the dose-response curve as the concentration of a medication increases?

    <p>It starts flat, then rises, and eventually flattens again.</p> Signup and view all the answers

    What characterizes the Gq protein's action in the signaling pathway?

    <p>It activates phospholipase C.</p> Signup and view all the answers

    What defines efficacy in the context of a medication's action?

    <p>The maximum effect a medication can produce.</p> Signup and view all the answers

    What distinguishes medication A from medication B regarding their dose-response curves?

    <p>Medication A requires a lower EC50 than medication B to reach half of Emax.</p> Signup and view all the answers

    Which statement best defines the term 'affinity' in pharmacological interactions?

    <p>The strength of the chemical bond between medication and receptor.</p> Signup and view all the answers

    What causes the dose-response curve to start to flatten out at high medication concentrations?

    <p>All receptors become activated and cannot respond further.</p> Signup and view all the answers

    Which statement accurately describes the relationship between affinity and potency?

    <p>Higher affinity is directly proportional to higher potency.</p> Signup and view all the answers

    What is the significance of the second messengers IP3, DAG, and cAMP in cellular signaling?

    <p>They stimulate or inhibit different sets of enzymes and pathways.</p> Signup and view all the answers

    Study Notes

    Pharmacodynamics

    • Pharmacodynamics refers to the mechanism of action of medications in the body
    • Medications bind to receptors on a cell's membrane or within the cell
    • Receptors are specialized proteins
    • Binding to a receptor can alter cell activity or behavior

    Receptor Agonists

    • Agonists mimic the actions of the signal ligand
    • Agonists activate receptors upon binding
    • Full agonists produce maximal response (Emax)
    • Partial agonists produce a submaximal response, even at high doses

    Receptor Antagonists

    • Antagonists block receptor activation
    • They bind to receptors but do not activate them
    • Competitive antagonists bind to the same site as the agonist
    • Non-competitive antagonists bind to a different site, called the allosteric site

    Competitive Antagonists

    • Bind reversibly to the same site as agonists
    • Can be overcome by increasing the concentration of the agonist
    • Shift the dose-response curve to the right, increasing the ED50
    • Decrease agonist potency but do not affect agonist efficacy

    Non-Competitive Antagonists

    • Bind irreversibly to the same site as agonists or to the allosteric site
    • Cannot be overcome by increasing the concentration of the agonist
    • Reduce agonist efficacy without affecting agonist potency
    • Decrease the Emax of an agonist
    • Do not affect the ED50 of an agonist

    Summary

    • Agonists: Activate receptors and can be divided into full and partial agonists.
    • Antagonists: Prevent receptor activation and can be competitive or non-competitive.
    • Competitive antagonism is surmountable, while non-competitive antagonism is not.

    Receptor Desensitization & Tolerance

    • Receptor desensitization is a rapid decrease in the responsiveness of a receptor to its agonist. It occurs within minutes and is also called tachyphylaxis.
    • Receptor tolerance is a gradual decrease in the responsiveness of a receptor to its agonist, occurring over days to weeks.

    Mechanisms of Desensitization and Tolerance

    • Downregulation: Chronic exposure to agonists reduces the number of receptors on the cell surface by decreasing receptor synthesis or increasing receptor degradation.
    • Internalization/Sequestration: Receptors are internalized and sent to lysosomes for degradation.
    • Uncoupling: Receptors are modified, preventing them from activating their intracellular signaling pathway.
      • This is a rapid mechanism primarily responsible for desensitization.
    • G-Protein Coupled Receptor (GPCR) Phosphorylation and Arrestin Binding:
      • GPCRs can be phosphorylated by GPCR kinases (GRKs) in response to high agonist concentrations.
      • Phosphorylated receptors bind to arrestins, preventing receptor activation and signaling.
      • Arrestins also tag receptors for endocytosis, further reducing their number on the cell membrane.
    • Exhaustion of Intermediate Messenger Molecules: Some drugs deplete critical messenger molecules, diminishing their effectiveness with repeated use.
      • For example, continuous amphetamine use can deplete the amine stores (dopamine, serotonin, and norepinephrine) at nerve terminals.
    • Increased Metabolic Breakdown of the Medication: Chronic use can lead to increased production of enzymes that metabolize the drug, reducing its effectiveness.
      • For example, alcohol tolerance is linked to increased ethanol metabolism.
    • Decreased Metabolism of the Medication: Tolerance can also occur due to decreased metabolism of the drug, leading to a lower concentration of its active metabolite.
      • For example, tolerance to nitroglycerin develops because its active metabolite, nitric oxide, is metabolized more slowly.
    • Physiological Adaptation: The body can adapt to the effects of a drug, limiting its effectiveness.
      • For example, thiazide diuretics can become less effective in lowering blood pressure as the renin-angiotensin-aldosterone system increases its activity to compensate.

    Intracellular Receptors

    • Located in the cytoplasm or nucleus of the cell
    • Bind to small, hydrophobic ligands (e.g. steroids)
    • Receptor-ligand complex binds to specific DNA sequences to activate or inhibit gene expression

    Cell-Surface Receptors

    • Embedded in the plasma membrane
    • Bind to large or hydrophilic ligands
    • Three main types: ligand-gated ion channels, enzyme-coupled receptors, and G-protein coupled receptors

    Ligand-Gated Ion Channels

    • Form closed channels or pores
    • Open when a specific ligand binds, allowing ions to passively flow through the membrane (e.g., chloride, calcium, sodium, potassium)
    • Trigger signaling pathways

    Enzyme-Coupled Receptors

    • Usually single-pass transmembrane proteins
    • Extracellular end binds to ligands
    • Intracellular end has enzymatic activity (usually a tyrosine kinase)
    • Ligand binding triggers phosphorylation of other molecules
    • Phosphorylated molecules activate proteins in the signal pathway

    G-Protein Coupled Receptors

    • Seven-pass transmembrane receptors
    • Ligand binding activates G proteins (alpha, beta, and gamma subunits)
    • Inactive G protein has alpha subunit bound to GDP
    • Ligand binding causes alpha subunit to release GDP and bind GTP
    • GTP-bound alpha subunit detaches and activates other proteins in the signaling pathway

    Types of G Proteins

    • Gq: Activates phospholipase C, which cleaves PIP2 into IP3 and DAG
    • Gs: Stimulates adenylate cyclase, which converts ATP to cAMP
    • Gi: Inhibits adenylate cyclase, which reduces cAMP production

    Second Messengers

    • IP3, DAG, and cAMP are second messengers
    • They activate or inhibit specific enzymes and molecular pathways
    • e.g., DAG activates protein kinase C, cAMP activates protein kinase A

    Medication-Receptor Interactions

    • Affinity: Strength of the bond between a medication and its receptor
    • Potency: Amount of medication needed to elicit an effect (high potency = less medication needed)
    • Efficacy: Maximal effect a medication can produce

    Dose-Response Curve

    • Plots medication concentration (x-axis) against response (y-axis)
    • Shape is S-shaped
    • Emax: Maximum response (measures efficacy)
    • EC50: Concentration at which 50% of the maximum effect is produced (inversely proportional to potency)

    Comparing Potency and Efficacy

    • Medications with higher potency have lower EC50 values
    • Medications with higher efficacy have higher Emax values
    • Medications can have the same efficacy but different potencies, or vice versa

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the fundamental principles of pharmacodynamics, including the actions of receptor agonists and antagonists in the body. Understand how medications interact with receptor sites and the implications of full versus partial agonists. Test your knowledge on competitive and non-competitive antagonists and their effects on cell activity.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser